3-,8-SUBSTITUTED DEUTEROPORPHYRINE DERIVATIVES, PHARMACEUTICALS CONTAINING THEM AND METHODS OF PRODUCING THEM

3-,8-SUBSTITUTED DEUTEROPORPHYRINE DERIVATIVES, PHARMACEUTICALS CONTAINING THEM AND METHODS OF PRODUCING THEM

Porphyrine-complex compounds consisting of a ligand of formula (I) and at least one ion of an element of atomic number 21-32, 37-39, 42-51 or 57-83, wherein R2 stands for R3, a -CO-Z group of a -(NH)o-(A)-q-NH-D group,.R3 stands for a -(C = M)(NR4)o-(A)q-(NR5)-K group, and K stands for a complexing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GRIES, HEINZ, MAIER, FRANZ-KARL, GAIDA, JOSEF, EBERT, WOLFGANG, HILGER, CHRISTOPH-STEPHAN, NIEDBALLA, ULRICH, PLATZEK, JOHANNES, CONRAD, JURGEN, LEE-VAUPEL, MARY
Format: Patent
Sprache:eng ; fre
Schlagworte:
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Porphyrine-complex compounds consisting of a ligand of formula (I) and at least one ion of an element of atomic number 21-32, 37-39, 42-51 or 57-83, wherein R2 stands for R3, a -CO-Z group of a -(NH)o-(A)-q-NH-D group,.R3 stands for a -(C = M)(NR4)o-(A)q-(NR5)-K group, and K stands for a complexing agent of general formula (IIa) or (IIb), pharmaceuticals containing these compounds, their use in diagnostics and therapy as well as methods of producing them.